Literature DB >> 16595769

The retinoic acid paradox in cancer chemoprevention.

Sarah J Freemantle, Konstantin H Dragnev, Ethan Dmitrovsky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16595769     DOI: 10.1093/jnci/djj116

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  9 in total

Review 1.  MicroRNA and cancer chemoprevention.

Authors:  Bin Yi; Gary A Piazza; Xiulan Su; Yaguang Xi
Journal:  Cancer Prev Res (Phila)       Date:  2013-03-26

Review 2.  Treatment for Barrett's oesophagus.

Authors:  Jonathan Re Rees; Pierre Lao-Sirieix; Angela Wong; Rebecca C Fitzgerald
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

3.  PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions.

Authors:  Miroslaw J Szczepanski; Albert B DeLeo; Michał Łuczak; Marta Molinska-Glura; Jan Misiak; Bronislawa Szarzynska; Grzegorz Dworacki; Mariola Zagor; Natalia Rozwadowska; Maciej Kurpisz; Antoni Krzeski; Aleksandra Kruk-Zagajewska; Tomasz Kopec; Jacek Banaszewski; Theresa L Whiteside
Journal:  Oral Oncol       Date:  2012-09-01       Impact factor: 5.337

4.  Foodstuffs for preventing cancer: the preclinical and clinical development of berries.

Authors:  Gary D Stoner
Journal:  Cancer Prev Res (Phila)       Date:  2009-03-03

Review 5.  Retinoids: novel immunomodulators and tumour-suppressive agents?

Authors:  M R Carratù; C Marasco; G Mangialardi; A Vacca
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 6.  Vitamin A and retinoid derivatives for lung cancer: a systematic review and meta analysis.

Authors:  Heidi Fritz; Deborah Kennedy; Dean Fergusson; Rochelle Fernandes; Steve Doucette; Kieran Cooley; Andrew Seely; Stephen Sagar; Raimond Wong; Dugald Seely
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

7.  Tracing anti-cancer and cancer-promoting actions of all-trans retinoic acid in breast cancer to a RARα epigenetic mechanism of mammary epithelial cell fate.

Authors:  Stefano Rossetti; MingQiang Ren; Nicolo Visconti; Francesca Corlazzoli; Vincenzo Gagliostro; Giulia Somenzi; Jin Yao; Yijun Sun; Nicoletta Sacchi
Journal:  Oncotarget       Date:  2016-12-27

8.  All-trans-retinoic acid activates the pro-invasive Src-YAP-Interleukin 6 axis in triple-negative MDA-MB-231 breast cancer cells while cerivastatin reverses this action.

Authors:  Belén Mezquita; Pau Mezquita; Montserrat Pau; Laura Gasa; Lourdes Navarro; Mireia Samitier; Miquel Pons; Cristóbal Mezquita
Journal:  Sci Rep       Date:  2018-05-04       Impact factor: 4.379

Review 9.  Leukoplakia and Immunology: New Chemoprevention Landscapes?

Authors:  Roberto Grigolato; Maria Eleonora Bizzoca; Luca Calabrese; Stefania Leuci; Michele Davide Mignogna; Lorenzo Lo Muzio
Journal:  Int J Mol Sci       Date:  2020-09-19       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.